Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Friis

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 1, 1979
Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: studies of 3',5'-diiodothyronine metabolismJ Faber, C Kirkegaard, I B Lumholtz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1978
Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kineticsI B Lumholtz, K Siersbaek-Nielsen, J Faber, et al.
Lancet (London, England)|December 9, 1978
L--3',5'--diiodothyronine in human serumC Kirkegaard, J Faber, T Friis, et al.
Acta Endocrinologica|September 1, 1982
Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatmentH Bliddal, K Bech, P Hyltoft Petersen, et al.
Lancet (London, England)|March 8, 1980
Beta-blockers in thyrotoxicosisI B Lumholtz, J Faber, C Kirkegaard, et al.
Clinical Endocrinology|February 1, 1982
Metabolic clearance and production rates of 3.3'-diiodothyronine, 3',5'-diiodothyronine and 3'-monoiodothyronine in hyper- and hypothyroidismJ Faber, I B Lumholtz, C Kirkegaard, et al.
Clinical Endocrinology|September 1, 1978
Urinary excretion of 3,3',5'-triiodothyronine (reverse T3)J Faber, B C Kirkegaard, P Rogowski, et al.
Biomaterials|October 12, 2010
The influence of surface microroughness and hydrophilicity of titanium on the up-regulation of TGFβ/BMP signalling in osteoblastsJ Vlacic-Zischke, S M Hamlet, T Friis, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1989
Concentrations of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, 3,3'-diiodothyronine, and 3',5'-diiodothyronine in human red blood cellsC Bregengaard, C Kirkegaard, J Faber, et al.
Ugeskrift for Laeger|February 27, 1989
[The value of routine check-ups of patients after radical surgery of colonic cancer or rectal cancer]H V Clausen, L Kay, C J Erichsen, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|April 1, 1979
Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: studies of 3',5'-diiodothyronine metabolismJ Faber, C Kirkegaard, I B Lumholtz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1978
Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kineticsI B Lumholtz, K Siersbaek-Nielsen, J Faber, et al.
Lancet (London, England)|December 9, 1978
L--3',5'--diiodothyronine in human serumC Kirkegaard, J Faber, T Friis, et al.
Acta Endocrinologica|September 1, 1982
Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatmentH Bliddal, K Bech, P Hyltoft Petersen, et al.
Lancet (London, England)|March 8, 1980
Beta-blockers in thyrotoxicosisI B Lumholtz, J Faber, C Kirkegaard, et al.
Clinical Endocrinology|February 1, 1982
Metabolic clearance and production rates of 3.3'-diiodothyronine, 3',5'-diiodothyronine and 3'-monoiodothyronine in hyper- and hypothyroidismJ Faber, I B Lumholtz, C Kirkegaard, et al.
Clinical Endocrinology|September 1, 1978
Urinary excretion of 3,3',5'-triiodothyronine (reverse T3)J Faber, B C Kirkegaard, P Rogowski, et al.
Biomaterials|October 12, 2010
The influence of surface microroughness and hydrophilicity of titanium on the up-regulation of TGFβ/BMP signalling in osteoblastsJ Vlacic-Zischke, S M Hamlet, T Friis, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1989
Concentrations of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, 3,3'-diiodothyronine, and 3',5'-diiodothyronine in human red blood cellsC Bregengaard, C Kirkegaard, J Faber, et al.
Ugeskrift for Laeger|February 27, 1989
[The value of routine check-ups of patients after radical surgery of colonic cancer or rectal cancer]H V Clausen, L Kay, C J Erichsen, et al.
Pageof 11